Literature DB >> 30448422

Evaluation of ultrasonic vocalizations in a neurodevelopmental model of schizophrenia during the early life stages of rats.

Agnieszka Potasiewicz1, Malgorzata Holuj2, Diana Piotrowska2, Katarzyna Zajda2, Michal Wojcik2, Piotr Popik2, Agnieszka Nikiforuk2.   

Abstract

In an animal neurodevelopmental model of schizophrenia, we investigated ultrasonic communication and social behavior in male and female rats. Pregnant dams were treated with methylazoxymethanol acetate (MAM; 22 mg/kg) at 17 days of gestation. First, we examined the ultrasonic vocalizations (USVs) emitted by 8-day-old pups isolated from their mothers and placed in a familiar or an unfamiliar environment. Second, we assessed tickling-induced USVs, social play (SP) behavior and accompanying USVs in 30-day-old juveniles. Independent of the prenatal treatment, sex differences were noted at both ages. In the pups isolated from their mothers, compared to the females, the males produced flatter calls with a lower frequency. Compared to the females, the tickling-induced male USVs were characterized by a higher frequency, and the male SP-induced USVs showed a broader bandwidth and more modulated structure. Additionally, the numbers of both SP-induced USVs and SP episodes in the males were higher than those in the females. In contrast, the MAM exposure reduced the ultrasonic communication and social behavior independent of age almost equally in the male and female rats. The MAM-exposed isolated pups and juveniles experiencing tickling and social interaction displayed lower USV bandwidths, suggesting that the complexity of their ultrasonic communication was reduced. In addition, the MAM-exposed juveniles demonstrated a lower number of 50-kHz "happy calls" and decreased SP duration, which is suggestive of social withdrawal or negative-like symptoms. These data demonstrate that young MAM-exposed rats display an atypical repertoire of USVs and reduced play behavior suggestive of communication deficits associated with schizophrenia.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Animal model of schizophrenia; Methylazoxymethanol acetate; Negative symptoms; Sex differences; Ultrasound vocalization; Young rats

Mesh:

Substances:

Year:  2018        PMID: 30448422     DOI: 10.1016/j.neuropharm.2018.11.023

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  6 in total

1.  A Protocol for the Non-invasive Method of Ultrasound Separation During the Sociosexual Vocal-Non-contact Model in Rats.

Authors:  Wiktor Bogacki-Rychlik; Anna Wrona; Michal Bialy
Journal:  Front Behav Neurosci       Date:  2022-05-25       Impact factor: 3.617

2.  Increased self-triggered vocalizations in an epidermal growth factor-induced rat model for schizophrenia.

Authors:  Itaru Narihara; Hanako Yokoyama; Hisaaki Namba; Hidekazu Sotoyama; Hiroyoshi Inaba; Eiko Kitayama; Kota Tamada; Toru Takumi; Hiroyuki Nawa
Journal:  Sci Rep       Date:  2022-07-28       Impact factor: 4.996

3.  Sex differences in 50 kHz call subtypes emitted during tickling-induced playful behaviour in rats.

Authors:  Emma K L Tivey; Jessica E Martin; Sarah M Brown; Vincent Bombail; Alistair B Lawrence; Simone L Meddle
Journal:  Sci Rep       Date:  2022-09-12       Impact factor: 4.996

Review 4.  Biological Functions of Rat Ultrasonic Vocalizations, Arousal Mechanisms, and Call Initiation.

Authors:  Stefan M Brudzynski
Journal:  Brain Sci       Date:  2021-05-09

5.  Serotonin transporter deficiency alters socioemotional ultrasonic communication in rats.

Authors:  Joanna Golebiowska; Małgorzata Hołuj; Agnieszka Potasiewicz; Diana Piotrowska; Agata Kuziak; Piotr Popik; Judith R Homberg; Agnieszka Nikiforuk
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

6.  The Effect of Maternal Immune Activation on Social Play-Induced Ultrasonic Vocalization in Rats.

Authors:  Kinga Gzielo; Agnieszka Potasiewicz; Ewa Litwa; Diana Piotrowska; Piotr Popik; Agnieszka Nikiforuk
Journal:  Brain Sci       Date:  2021-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.